Bayer Plans to Double Down on US Pharma R&D in 2023
Bayer plans to substantially increase investment in U.S.-based pharmaceutical R&D, earmarking $1 billion to invest stateside in 2023.
Bayer Plans to Double Down on US Pharma R&D in 2023 Read More »
Uncategorized
QurAlis’ Biomarker-Driven Approach Attracts $88M in Series B
QurAlis has taken a biomarker-driven approach to treating ALS all the way to another bank deposit, closing an oversubscribed $88 million Series B round Thursday.
QurAlis’ Biomarker-Driven Approach Attracts $88M in Series B Read More »
Impresión 4D de materiales inteligentes
Unos científicos han creado una impresora 4D para materiales inteligentes con propiedades magnéticas y electromecánicas. Estos científicos, de la Universidad Carlos III de Madrid (UC3M) en España, han creado el software y el hardware de dicha impresora 4D, …
¿El agua de la Tierra es más antigua que el Sol?
Se ha detectado agua en forma de gas en el disco de formación planetaria que rodea a la estrella V883 Orionis. Este agua lleva una firma química que explicaría el viaje del agua desde las nubes de gas de formación estelar hasta los planetas, apoyando la idea de que el agu …
¿El agua de la Tierra es más antigua que el Sol? Read More »
Teva and Natco Announce Launch of additional strengths for the Generic Version of Revlimid® (lenalidomide capsules), in the U.S.
Teva Pharmaceuticals and NATCO Pharma Limited (NSE: NATCOPHARM; BSE: 524816), announced today the launch of additional strengths for the generic version of Revlimid® 1 (lenalidomide capsules), in 2.5 mg, and 20 mg strengths, in the United States.
Ansa Biotechnologies Announces Successful de novo Synthesis of World’s Longest Oligonucleotide at 1005 Bases
Ansa Biotechnologies, Inc today announced the successful de novo synthesis of the world’s longest DNA oligonucleotide ever reported to be produced in a single synthesis.
¿Adiós al café?
El café lo consume mucha gente en el mundo y es importante para las economías de las regiones productoras. ¿Hasta qué punto el cambio climático global puede volver inviable la producción de café en dichas regiones? Un estudio llevado a cabo p …
NRx Pharmaceuticals Announces Close of $2.9 Million Registered Direct Offering
NRx Pharmaceuticals received approximately $2.9 million in cash from existing investors.
NRx Pharmaceuticals Announces Close of $2.9 Million Registered Direct Offering Read More »
ANI Pharmaceuticals Reports Record Fourth Quarter Financial Results and Achieves Full Year 2022 Revenue Milestone; Initiates 2023 Guidance
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced business highlights and financial results for the three and 12 months ended December 31, 2022.
Evofem Biosciences Appoints Interim Chief Financial Officer
Evofem Biosciences, Inc. (OTCQB: EVFM) is pleased to announce the appointment of Albert Altro as Interim Chief Financial Officer of the Company.
Evofem Biosciences Appoints Interim Chief Financial Officer Read More »